Marrero JA - Search Results

1

AASLD guidelines for the treatment of hepatocellular carcinoma.

Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. Heimbach JK, et al. Among authors: marrero ja. Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086. Hepatology. 2018. PMID: 28130846 No abstract available.

2

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. Marrero JA, et al. Hepatology. 2002 Dec;36(6):1349-54. doi: 10.1053/jhep.2002.36939. Hepatology. 2002. PMID: 12447858 Free article.

3

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Marrero JA, et al. Hepatology. 2003 May;37(5):1114-21. doi: 10.1053/jhep.2003.50195. Hepatology. 2003. PMID: 12717392

4

Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma.

Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Marrero JA, et al. J Hepatol. 2005 Feb;42(2):218-24. doi: 10.1016/j.jhep.2004.10.005. J Hepatol. 2005. PMID: 15664247

5

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

Schwegler EE, Cazares L, Steel LF, Adam BL, Johnson DA, Semmes OJ, Block TM, Marrero JA, Drake RR. Schwegler EE, et al. Among authors: marrero ja. Hepatology. 2005 Mar;41(3):634-42. doi: 10.1002/hep.20577. Hepatology. 2005. PMID: 15726646

6

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Marrero JA, Fontana RJ, Barrat A, Askari F, Conjeevaram HS, Su GL, Lok AS. Marrero JA, et al. Hepatology. 2005 Apr;41(4):707-16. doi: 10.1002/hep.20636. Hepatology. 2005. PMID: 15795889 Free article.

7

Hepatocellular carcinoma.

Marrero JA. Marrero JA. Curr Opin Gastroenterol. 2005 May;21(3):308-12. doi: 10.1097/01.mog.0000159817.55661.ca. Curr Opin Gastroenterol. 2005. PMID: 15818151 Review.

8

GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma.

Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D'Amelio A, Lok AS, Block TM. Marrero JA, et al. J Hepatol. 2005 Dec;43(6):1007-12. doi: 10.1016/j.jhep.2005.05.028. Epub 2005 Jun 28. J Hepatol. 2005. PMID: 16137783

9

Diagnosis and treatment of hepatocellular carcinoma.

El-Serag HB, Marrero JA, Rudolph L, Reddy KR. El-Serag HB, et al. Among authors: marrero ja. Gastroenterology. 2008 May;134(6):1752-63. doi: 10.1053/j.gastro.2008.02.090. Gastroenterology. 2008. PMID: 18471552 Review.

10

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M. Marrero JA, et al. Gastroenterology. 2009 Jul;137(1):110-8. doi: 10.1053/j.gastro.2009.04.005. Epub 2009 Apr 9. Gastroenterology. 2009. PMID: 19362088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page